BridgeMD
Compares treatment options for Intravenous
Official title Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT
ClinicalTrials.gov ID: NCT06498323
What this study is testing
What is tenecteplase?
tenecteplase is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for intravenous.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Acute ischemic stroke is one of the devastating diseases that increase hospitalization, disabilities, and deaths worldwide. Current treatment with intravenous thrombolytic agent can help reduce disabilities and improve quality of life.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Diagnosed as Acute ischemic stroke within 4.5 hr of symptom onset
- Age \> 18 years old
- No contraindication for thrombolytic drug
- Informed consent from patients
You likely can't join if
- Diagnosed as Acute ischemic stroke with more than 4.5 hours of symptom onset or uncontained onset
- Have contraindication for thrombolytic drugs
The study team makes the final eligibility decision.
Where it's taking place
- Bangkok, Thailand
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bangkok, Thailand. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.